Treatment resistance and other complicating factors in the management of schizophrenia.
Treatment resistance, along with its sibling partial response, remains a common phenomenon in schizophrenia, complicating the disability burden inherent in the disease. Antipsychotic medications are the mainstay of treatment, and treatment resistance has mainly been defined in terms of poor response to antipsychotic medication. At the same time, clozapine, the most effective antipsychotic, remains underutilized at the expense of exposing patients to polypharmacy. We review known causes of disability in schizophrenia, how they impact various areas of everyday functioning, and discuss potential treatment options including but not limited to pharmacological approaches aimed at maximizing treatment response and reducing treatment resistance.
['Strassnig|Martin T|MT|', 'Harvey|Philip D|PD|']
D000928:Antidepressive Agents D014150:Antipsychotic Agents D015928:Cognitive Behavioral Therapy D003863:Depression D006801:Humans D012559:Schizophrenia D012565:Schizophrenic Psychology
schizophrenia Chronic cognition health refractory